Factors associated with mortality after breast cancer metastasis. Cancer Causes Control, vol.23, pp.103-115, 2012. ,
Baseline staging of newly diagnosed breast Cancer -Kuwait Cancer control center experience, Med Princ Pract, vol.16, issue.1, pp.22-26, 2007. ,
Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy, Am J Obstet Gynecol, vol.196, issue.4, pp.342-343, 2007. ,
Metastatic behavior of breast Cancer subtypes, J Clin Oncol, vol.28, issue.20, pp.3271-3278, 2010. ,
Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients, Med Oncol, vol.30, issue.1, pp.388-96, 2013. ,
Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment, Clin Breast Cancer, vol.13, pp.88-94, 2013. ,
Prognostic factors in 401 elderly women with metastatic breast Cancer, Oncology, vol.86, issue.3, pp.143-51, 2014. ,
Is liver resection justified for patients with hepatic metastases from breast cancer?, Ann Surg, vol.244, pp.897-907, 2006. ,
Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model, Ann Surg, vol.244, pp.524-559, 2006. ,
Repeat hepatectomy for breast Cancer liver metastases, Ann Surg Oncol, vol.22, issue.3, pp.1057-66, 2015. ,
Predictive profile-nomogram for liver resection for breast Cancer metastases: an aggressive approach with promising results, Ann Surg Oncol, vol.24, pp.535-580, 2017. ,
Long-term survival and cure model following liver resection for breast cancer metastases, Breast Cancer Res Treat, vol.170, issue.1, 2018. ,
Clinical implications of routine genomic mutation sequencing in PIK3CA/ AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer, Breast Cancer Res Treat, vol.160, pp.69-77, 2016. ,
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival, Ann Oncol, vol.26, pp.81-89, 2015. ,
Oncogenes and tumor suppressor genes, Cold Spring Harb Perspect Biol, vol.2, p.3236, 2010. ,
Phosphoinositide 3-kinase mutations in breast cancer: a "good" activating mutation? Clin Cancer Res, vol.15, pp.5017-5026, 2009. ,
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma, Breast Cancer Res Treat, vol.120, pp.409-427, 2010. ,
Phosphatidylinositol 3-kinase (PI3KCA) oncogene mutation analysis and gene expression profiling in primary breast cancer patients, Asian Pac J Cancer Prev, vol.14, pp.5067-72, 2013. ,
PI3K pathway alterations in cancer: variations on a theme, Oncogene, vol.27, pp.5497-510, 2008. ,
Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?, Target Oncol, vol.10, issue.3, pp.415-436, 2015. ,
Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysis, J Mol Diagn, vol.14, pp.336-381, 2012. ,
Intratumoral heterogeneity for Ki-67 index in invasive breast carcinoma: a study on 131 consecutive cases, Appl Immunohistochem Mol Morphol, vol.25, issue.5, pp.338-378, 2017. ,
The clonal evolution of tumor cell populations, Science, vol.194, issue.4260, pp.23-31, 1976. ,
Intraepidermal cells of Paget's carcinoma of the breast can be genetically different from those of the underlying carcinoma, Hum Pathol, vol.34, issue.12, pp.1321-1351, 2003. ,
Cell lineage analysis of a mouse tumor, Cancer Res, vol.68, issue.14, pp.5924-5955, 2008. ,
Tumor targeting using radiolabeled antibodies for image-guided drug delivery, Curr Drug Targets, vol.16, issue.6, pp.625-658, 2015. ,
The prognostic value of PI3K mutational status in breast cancer: a meta-analysis ,
, J Cell Biochem, vol.119, issue.6, pp.4287-92, 2018.